Inventor
NARLA RAMA KRISHNA
US18 patents
⚠️ This page may combine multiple inventors who share the name “NARLA RAMA KRISHNA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELGENE CORP
10 patentsUS11149007B2Oct 19, 2021
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith
CELGENE CORP14 citations84
US11325889B2May 10, 2022
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith
CELGENE CORP11 citations83
US11873283B2Jan 16, 2024
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith
CELGENE CORP2 citations71
US11666579B2Jun 6, 2023
Methods of treating hematological malignancies using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione
CELGENE CORP2 citations71
US12404241B2Sep 2, 2025
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith
CELGENE CORP0 citations61
US12178822B2Dec 31, 2024
Methods of treating hematological malignancies using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dion
CELGENE CORP0 citations60
US12103923B2Oct 1, 2024
Methods of treating non-hodgkin lymphoma using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione
CELGENE CORP0 citations60
US11390617B2Jul 19, 2022
Methods of treating non-Hodgkin lymphoma using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione
CELGENE CORP1 citations60
US12396995B2Aug 26, 2025
Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for combined use
CELGENE CORP0 citations57
US11583536B2Feb 21, 2023
Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for combined use
CELGENE CORP0 citations57
PARKER HUGHES INST
8 patentsUS6358962B2Mar 19, 2002
6,7-Dimethoxyquinazolines and therapeutic use thereof
PARKER HUGHES INST40 citations96
US6552027B2Apr 22, 2003
Quinazolines for treating brain tumor
PARKER HUGHES INST35 citations92
US6316454B1Nov 13, 2001
6,7-Dimethoxy-4-anilinoquinazolines
PARKER HUGHES INST24 citations92
US6258820B1Jul 10, 2001
Synthesis and anti-tumor activity of 6,7-dialkoxy-4-phenylamino-quinazolines
PARKER HUGHES INST17 citations92
US6251882B1Jun 26, 2001
Alkyl ketones as potent anti-cancer agents
PARKER HUGHES INST16 citations79
US6638939B2Oct 28, 2003
6,7-dimethoxyquinazolines and therapeutic use thereof
PARKER HUGHES INST8 citations73
US7038049B2May 2, 2006
Haloanilino quinazolines and therapeutic use thereof
PARKER HUGHES INST0 citations52
US6878388B1Apr 12, 2005
Vanadium compounds for treating proliferative cell disorders
PARKER HUGHES INST0 citations52